Business Description
Infinity Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US45665G3039
Description
Infinity Pharmaceuticals Inc is a clinical-stage biopharmaceutical company dedicated to developing novel medicines for people with cancer. It combines proven scientific expertise with a passion for developing novel small molecule drugs that target disease pathways for potential applications in oncology. It is focused on advancing eganelisib, also known as IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that reprograms macrophages through selective inhibition of the enzyme phosphoinositide-3-kinase-gamma, or PI3K-gamma.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 55.56 | |||||
9-Day RSI | 52.94 | |||||
14-Day RSI | 51.85 | |||||
12-1 Month Momentum % | 900 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -1513.59 | |||||
OCF Margin % | -1513.59 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 2 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:INFIQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Infinity Pharmaceuticals Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.569 | ||
| EPS (TTM) ($) | -0.46 | ||
| Beta | -12.7369 | ||
| 3-Year Sharpe Ratio | 0.05 | ||
| 3-Year Sortino Ratio | 0.12 | ||
| Volatility % | 403.39 | ||
| 14-Day RSI | 51.85 | ||
| 14-Day ATR ($) | 0.000007 | ||
| 20-Day SMA ($) | 0.000096 | ||
| 12-1 Month Momentum % | 900 | ||
| 52-Week Range ($) | 0.00001 - 0.0001 | ||
| Shares Outstanding (Mil) | 90.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Infinity Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Infinity Pharmaceuticals Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-13 | In 124 days | ||
| Third quarter earnings results for 2026 | 2026-11-13 | In 124 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-20 | In 39 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 39 days | ||
| First quarter earnings conference call for 2026 | 2026-07-17 | In 5 days | ||
| First quarter earnings results for 2026 | 2026-07-17 | In 5 days | ||
| 0.25:1 Stock Split | 2006-09-13 | 15.04 (+0.27%) |
Show
Entries
Infinity Pharmaceuticals Inc Frequently Asked Questions
What is Infinity Pharmaceuticals Inc(INFIQ)'s stock price today?
The current price of INFIQ is $0.00. The 52 week high of INFIQ is $0.00 and 52 week low is $0.00.
When is next earnings date of Infinity Pharmaceuticals Inc(INFIQ)?
The next earnings date of Infinity Pharmaceuticals Inc(INFIQ) is 2026-07-17 Est..
Does Infinity Pharmaceuticals Inc(INFIQ) pay dividends? If so, how much?
Infinity Pharmaceuticals Inc(INFIQ) does not pay dividend.
Guru Commentaries on OTCPK:INFIQ
No articles.
Press Release
Articles on Infinity Pharmaceuticals Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers